Bespak

Bespak is a leading global contract development and manufacturing organization (CDMO) specializing in drug delivery devices and combination products. The company provides comprehensive services for the design, development, and high-volume manufacture of inhalation, nasal, and injectable delivery systems. Bespak is renowned for its expertise in pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and advanced autoinjector technologies. A key focus for the company is leading the transition to sustainable, low-global warming potential (GWP) propellants in respiratory medicine. With multiple state-of-the-art facilities in the United Kingdom, Bespak supports pharmaceutical partners from early-stage feasibility through to full-scale commercial production. The company was recently established as a standalone entity following a carve-out from Recipharm by investment firm Lindsay Goldberg.